Biomarkers of laryngeal squamous cell carcinoma: a review

M Cavaliere, A Bisogno, A Scarpa, A D'Urso… - Annals of Diagnostic …, 2021 - Elsevier
Laryngeal carcinoma is the second common malignancy of the upper aerodigestive tract
after lung cancer; in most cases is a squamous cell carcinoma, whose risk factors include …

[HTML][HTML] Association between interleukin-6 and head and neck squamous cell carcinoma: A systematic review

U Uz, G Eskiizmir - Clinical and experimental …, 2021 - synapse.koreamed.org
Abstract Interleukin-6 (IL-6) is a proinflammatory cytokine which plays an important role in
several regulatory mechanisms of cancer. Moreover, experimental and clinical studies have …

[HTML][HTML] Clinical, histological and immunohistochemical evaluation of larynx cancer

MS Ciolofan, AN Vlăescu, CA Mogoantă… - Current health …, 2017 - ncbi.nlm.nih.gov
Laryngeal cancer represents the malignant degeneration, of epithelial nature or from the
connective tissue, which starts in the constitutive elements of the larynx. Cancer localization …

HPV meets APOBEC: New players in head and neck cancer

G Riva, C Albano, F Gugliesi, S Pasquero… - International Journal of …, 2021 - mdpi.com
Besides smoking and alcohol, human papillomavirus (HPV) is a factor promoting head and
neck squamous cell carcinoma (HNSCC). In some human tumors, including HNSCC, a …

[HTML][HTML] Updated overview of current biomarkers in head and neck carcinoma

K Dahiya, R Dhankhar - World journal of methodology, 2016 - ncbi.nlm.nih.gov
Squamous cell cancer is the most common type of malignancy arising from the epithelial
cells of the head and neck region. Head and neck squamous cell carcinoma (HNSCC) is …

Retracted: Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR‐145‐5p/ROCK1 axis

S Zhuang, F Liu, P Wu - 2019 - Wiley Online Library
Laryngocarcinoma is the most common head and neck cancer and has a high incidence
and mortality, causing about 83 000 deaths per year worldwide. Our research aimed to …

Interim 18F-FDG PET/CT during chemoradiation therapy in the management of head and neck cancer patients: a systematic review

C Garibaldi, S Ronchi, M Cremonesi, L Gilardi… - International Journal of …, 2017 - Elsevier
Positron emission tomography (PET) is an imaging modality widely applied in oncology for
tumor staging, volume delineation in radiation therapy planning, and therapy response …

CCL20/CCR6 promotes cell proliferation and metastasis in laryngeal cancer by activating p38 pathway

E Lu, J Su, Y Zhou, C Zhang, Y Wang - Biomedicine & Pharmacotherapy, 2017 - Elsevier
Chemokine and its receptors play important roles in laryngeal cancer development and
progression. CCR6 is the receptor of CCL20 chemokine, but its function in laryngeal cancer …

IL6 and BCL3 expression are potential biomarkers in esophageal squamous cell carcinoma

SC Soares-Lima, IM Gonzaga, D Camuzi… - Frontiers in …, 2021 - frontiersin.org
Esophageal squamous cell carcinoma (ESCC) ranks among the most lethal tumors
worldwide, as a consequence of late detection and poor treatment response, evidencing the …

[HTML][HTML] The evaluation of pretreatment neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte ratio in patients with laryngeal neoplasms

G Eskiizmir, U Uz, E Onur, B Ozyurt… - Brazilian Journal of …, 2019 - SciELO Brasil
Introduction: Systemic inflammatory biomarkers are promising predictive and prognostic
factors for solid cancers. The neutrophil-lymphocyte ratio and derived neutrophil-lymphocyte …